Bottom line
FBTCX vs IBBQ: the short answer
FBTCX (Fidelity Advisor Biotechnology Fund) and IBBQ (Invesco Nasdaq Biotechnology ETF) are both mutual funds.
But IBBQ is far broader, holding 261 positions to 129 for FBTCX, so beyond the top names it adds exposure FBTCX doesn't have.
IBBQ is cheaper at 0.19% vs 1.69% — a difference of $150 a year per $10,000 invested.
Over one year, FBTCX returned +37.5% vs −0.6% for IBBQ (reporting dates differ).
Updated Nov 19, 2026
FBTCX vs IBBQ side by side
| FBTCX | IBBQ | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | Invesco |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 1.69% | 0.19% |
| Annual cost per $10k | $169 | $19 |
| 10-yr cost on $10k (prospectus) | $1,799 | $242 |
| Max front load | — | None |
| 12b-1 fee | 1% | — |
| 1-yr return | +37.5% | −0.6% |
| 5-yr return (annualized) | +6.8% | — |
| 10-yr return (annualized) | +7.7% | — |
| Best quarter | +30.3% | +12.0% |
| Worst quarter | −27.8% | −11.7% |
| Net assets (fund) | $2.2B | $67.4M |
| Number of holdings | 129 | 261 |
| Portfolio turnover | 54% | 17% |
| Returns as of | Sep 30, 2026 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
9 of FBTCX's top 25 holdings also appear in IBBQ's top 25.
| Holding | FBTCX | IBBQ |
|---|---|---|
| Gilead Sciences Inc | 5.70% | 7.39% |
| Alnylam Pharmaceuticals Inc | 3.62% | 3.19% |
| Insmed Inc | 3.05% | 1.83% |
| Revolution Medicines Inc | 3.00% | 2.48% |
| Argenx Se | 3.00% | 1.89% |
| Biogen Inc | 2.71% | 2.29% |
| Amgen Inc | 2.37% | 7.10% |
| Moderna Inc | 1.60% | 1.48% |
| Vertex Pharmaceuticals Inc | 1.39% | 7.38% |
Source: SEC Form N-PORT
FBTCX top 10
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%
IBBQ top 10
- Invesco Private Prime Fund — 14.20%
- Gilead Sciences, Inc. — 7.39%
- Vertex Pharmaceuticals Inc. — 7.38%
- Amgen Inc. — 7.10%
- Invesco Private Government Fund — 5.48%
- Regeneron Pharmaceuticals, Inc. — 5.08%
- Alnylam Pharmaceuticals, Inc. — 3.19%
- Revolution Medicines, Inc. — 2.48%
- Biogen Inc. — 2.29%
- Illumina, Inc. — 1.98%
FAQ
What is the difference between FBTCX and IBBQ?
Which is cheaper, FBTCX or IBBQ?
Should I own both FBTCX and IBBQ?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.